Table 1.
Gene | Cancer | Observed connections with hypomethylation | References |
---|---|---|---|
WSIP1 | OSCC | Higher expression of WSIP1 protein characteristic for patients with lymph node metastasis | Clausen et al. (2016) |
CSPG4 | HNSCC |
Worse clinical outcome Overexpression of mRNA and protein |
Warta et al. (2014) |
PD-L1 | HNSCC | Overexpression of PD-L1 protein | Franzen et al. (2018) |
PD-L2 | HNSCC | Upregulation of PD-L2 mRNA expression | Franzen et al. (2018) |
IL6 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
PTPN22 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
RUNX1 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
CD28 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
CD22 | OSCC | No data related to gene expression | Basu et al. (2017) |
CD80 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
TLR1 | OSCC | Upregulation of gene expression | Basu et al. (2017) |
TNFa | OSCC | Upregulation of gene expression | Basu et al. (2017) |
APEX2 | HNSCC | Decreased mRNA expression in tumor | Chaisaingmongkol et al. (2012) |
TREX2 | HNSCC | No data related to gene expression | Chaisaingmongkol et al. (2012) |
MSH4 | HNSCC | Decreased mRNA expression in tumor | Chaisaingmongkol et al. (2012) |
MIR296 | OSCC | No date related to gene expression | Morandi et al. (2017) |
TERT | OSCC | No date related to gene expression | Morandi et al. (2017) |
GP1BB | OSCC | No date related to gene expression | Morandi et al. (2017) |